Alexander S, Moloney L, Kilpatrick N. Endodontic management of a patient with X-linked hypophosphataemic rickets. Aust Endod J. 2001;27(2):57–61.
Ariceta G, Beck-Nielsen SS, Boot AM, et al. The international X-linked hypophosphatemia (XLH) registry: first interim analysis of baseline demographic, genetic and clinical data. Orphanet J Rare Dis. 2023;18(1):304.
Article PubMed PubMed Central Google Scholar
Baroncelli GI, Zampollo E, Manca M, et al. Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets. J Bone Miner Metab. 2021;39(2):212–23.
Bradley H, Dutta A, Philpott R. Presentation and non-surgical endodontic treatment of two patients with X-linked hypophosphatemia: a case report. Int Endod J. 2021;54(8):1403–14.
Brener R, Zeitlin L, Lebenthal Y, Brener A. Dental health of paediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy. Front Endocrinol. 2022;13:947814.
Chadwick BL, Aldred MJ. An unusual giant cell lesion in a child with vitamin D-resistant rickets. Int J Paediatr Dent. 1992;2(1):41–5.
Chanchlani R, Nemer P, Sinha R, et al. An overview of rickets in children. Kidney Int Rep. 2020;5(7):980–90.
Article PubMed PubMed Central Google Scholar
Chavez MB, Kramer K, Chu EY, Thumbigere-Math V, Foster BL. Insights into dental mineralization from three heritable mineralization disorders. J Struct Biol. 2020;212(1):107597.
Article PubMed PubMed Central Google Scholar
Chen X, Cai C, Lun S, et al. The contribution of a novel PHEX gene mutation to X-linked hypophosphatemic rickets: a case report and an analysis of the gene mutation dosage effect in a rat model. Front Endocrinol. 2023;14:1251718.
Cremonesi I, Nucci C, D’Alessandro G, Alkhamis N, Marchionni S, Piana G. X‐linked hypophosphatemic rickets: enamel abnormalities and oral clinical findings. Scanning. 2014;36(4):456–61.
Douyere D, Joseph C, Gaucher C, Chaussain C, Courson F. Familial hypophosphatemic vitamin D-resistant rickets—prevention of spontaneous dental abscesses on primary teeth: a case report. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodontol. 2009;107(4):525–30.
Emma F, Cappa M, Antoniazzi F, et al. X-linked hypophosphatemic rickets: an Italian experts’ opinion survey. Ital J Pediatr. 2019;45(1):67.
Article PubMed PubMed Central Google Scholar
Francis F, Hennig S, Korn B, et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets. Nat Genet. 1995;11(2):130–6.
Gadion M, Hervé A, Herrou J, et al. Burosumab and dental abscesses in children with X-linked hypophosphatemia. JBMR plus. 2022;6(11):e10672.
Article PubMed PubMed Central Google Scholar
Gao Y, Wang ZM, Li XL. Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: two case reports. Medicine. 2018;97(31):e11453.
Article PubMed PubMed Central Google Scholar
Goodman H, Gelbier S, Bennett J, Winter G. Dental problems associated with hypophosphataemic vitamin D resistant rickets. Int J Paediatr Dent. 1998;8(1):19–28.
Guevara-Canales JOG, Zuñiga NC, Pastor MC, Trubnykova M, Vadillo RM. Prevalence of oral manifestations of hypophosphatemic rickets in patients treated in a Peruvian paediatric hospital. J Oral Res. 2020;9(5):383–91.
Haffner D, Emma F, Eastwood DM, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019;15(7):435–55.
Article PubMed PubMed Central Google Scholar
Innes NP, Evans DJ, Stirrups DR. The hall technique: a randomized controlled clinical trial of a novel method of managing carious primary molars in general dental practice: acceptability of the technique and outcomes at 23 months. Smile Dent J. 2012;110(431):1.
Janssens Y, Duplan MB, Linglart A, et al. Orthodontic treatment in children and adolescent patients with X-linked hypophosphatemia: a case-control study. Orthod Craniofac Res. 2024;27(5):697–703.
Jin C, Zhang C, Ni X, et al. The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study. Osteoporos Int. 2022;33(6):1385–95.
Article PubMed PubMed Central Google Scholar
Jin X, Xu Y, Liu W, et al. Dental manifestations and treatment of hypophosphatemic rickets: a case report and review of literature. BDJ Open. 2023;9(1):2.
Article PubMed PubMed Central Google Scholar
Lecoq AL, Brandi ML, Linglart A, Kamenický P. Management of X-linked hypophosphatemia in adults. Metabolism. 2020;103:154049.
Liu S, Guo R, Simpson LG, et al. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem. 2003;278(39):37419–26.
Marin A, Morales P, Jiménez M, et al. Characterization of oral health status in Chilean patients with X-linked hypophosphatemia. Calcif Tissue Int. 2021;109(2):132–8.
McWhorter AG, Seale NS. Prevalence of dental abscess in a population of children with vitamin D-resistant rickets. Paediatr Dent. 1991;13(2):91–6.
Okawa R, Takagi M, Nakamoto T, Kakimoto N, Nakano K. Evaluation of dental manifestations in X-linked hypophosphatemia using orthopantomography. PLoS ONE. 2024;19(7):e0307896.
Article PubMed PubMed Central Google Scholar
Paredes SEY, Segato RAB, Moreira LD, et al. Dentoalveolar abscesses not associated with caries or trauma: a diagnostic hallmark of hypophosphatemic rickets initially misdiagnosed as hypochondroplasia. Head Neck Pathol. 2018;12(4):604–9.
Rabbani A, Rahmani P, Ziaee V, Ghodoosi S. Dental problems in hypophosphatemic rickets: a cross-sectional study. Iran J Pediatr. 2012;22(4):531–4.
PubMed PubMed Central Google Scholar
Seow WK, Needleman HL, Holm IA. Effect of familial hypophosphatemic rickets on dental development: a controlled, longitudinal study. Paediatr Dent. 1995;17(5):346–50.
Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429–35.
Shroff DV, McWhorter AG, Seale NS. Evaluation of aggressive pulp therapy in a population of vitamin D-resistant rickets patients: a follow-up of 4 cases. Paediatr Dent. 2002;24(4):347–9.
Souza MA, Soares Junior LA, Santos MA, Vaisbich MH. Dental abnormalities and oral health in patients with hypophosphatemic rickets. Clinics (Sao Paulo). 2010;65(10):1023–6.
Su JM, Li Y, Ye XW, Wu ZF. Oral findings of hypophosphatemic vitamin D-resistant rickets: report of two cases. Chin Med J. 2007;120(16):1468–70.
Uday S, Shaw NJ, Mughal MZ, Randell T, Högler W, Santos R, et al. Monitoring response to conventional treatment in children with XLH: value of ALP and rickets severity score (RSS) in a real world setting. Bone. 2021;151:116025.
Ward LM, Glorieux FH, Whyte MP, Munns CF, Portale AA, Högler W, et al. Effect of burosumab compared with conventional therapy on younger vs older children with X-linked hypophosphatemia. J Clin Endocrinol Metab. 2022;107(8):e3241–53.
Article PubMed PubMed Central Google Scholar
Whyte MP, Carpenter TO, Gottesman GS, et al. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. Lancet Diabetes Endocrinol. 2019;7(3):189–99.
Comments (0)